TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
STOK

Stoke Therapeutics Inc

Healthcare · Biotechnology

26.10$ -10.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement STOK
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0%
74.3% 28.5% 53.9% 12.2%
-74.3% 100.0% 100.0% 100.0% 100.0%
1,805.6% 627.5% 936.6% 243.8% 74.8%
1,063.2% 313.8% 470.6% 133.5% 36.4%
2,868.8% 941.2% 1,407.2% 377.3% 111.2%
-2,868.8% -841.2% -1,307.2% -277.3% -11.2%
4.0% 25.2% 112.8% 34.6% 0.0%
-2,860.2% -814.7% -1,192.5% -243.4% -3.7%
-36.5% -64.1% 51.9% -243.4%
-2,823.7% -750.6% -1,192.5% -243.4% -3.7%
-2,836.4% -828.8% -1,164.4% -237.5% -2.8%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?